RetractedArticleBioscience reports2019

HER2 decreases drug sensitivity of ovarian cancer cells via inducing stem cell-like property in an NFκB-dependent way.

Wenxiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.